424 related articles for article (PubMed ID: 19332240)
1. Recent clinical trials of antiplatelet therapy in secondary stroke prevention: expectations and results for application in primary care settings.
Lutsep HL
Am J Med; 2009 Apr; 122(4 Suppl 2):S21-31. PubMed ID: 19332240
[TBL] [Abstract][Full Text] [Related]
2. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
3. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
Kirshner HS
Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
[TBL] [Abstract][Full Text] [Related]
4. Determining the appropriateness of selected surgical and medical management options in recurrent stroke prevention: a guideline for primary care physicians from the National Stroke Association work group on recurrent stroke prevention.
Hanley D; Gorelick PB; Elliott WJ; Broder MS; Saver JL; Kidwell CS; Fagan SC; Wilson A; Lennihan L; Schwer WA; Rubenstein LZ; Crowell RM; Haines SJ; Lopez CC; Zorowitz R; Dubois RW
J Stroke Cerebrovasc Dis; 2004; 13(5):196-207. PubMed ID: 17903976
[TBL] [Abstract][Full Text] [Related]
5. Newer antiplatelet therapies in stroke prevention.
Davis SM; Donnan GA
Aust Fam Physician; 2001 Feb; 30(2):129-34. PubMed ID: 11280112
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
Hankey GJ
Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet drugs for ischemic stroke prevention.
Leys D; Balucani C; Cordonnier C
Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet agents and randomized trials.
Diener HC
Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
Biller J
J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
[TBL] [Abstract][Full Text] [Related]
10. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
Gebel JM
J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
[TBL] [Abstract][Full Text] [Related]
11. The approach to optimizing stroke care.
Panagos PD
Am J Emerg Med; 2008 Sep; 26(7):808-16. PubMed ID: 18774049
[TBL] [Abstract][Full Text] [Related]
12. Acute ischemic coronary artery disease and ischemic stroke: similarities and differences.
Fisher M; Folland E
Am J Ther; 2008; 15(2):137-49. PubMed ID: 18356634
[TBL] [Abstract][Full Text] [Related]
13. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
Sztriha LK; VĂ©csei L
Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic interventions for prevention of recurrent ischemic stroke.
Kirshner HS
Am J Manag Care; 2008 Jun; 14(6 Suppl 2):S212-26. PubMed ID: 18611103
[TBL] [Abstract][Full Text] [Related]
15. Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?
Usman MH; Notaro LA; Nagarakanti R; Brahin E; Dessain S; Gracely E; Ezekowitz MD
Am J Cardiol; 2009 Apr; 103(8):1107-12. PubMed ID: 19361598
[TBL] [Abstract][Full Text] [Related]
16. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
Diener HC
Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
[TBL] [Abstract][Full Text] [Related]
17. New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management.
Lutsep HL
J Stroke Cerebrovasc Dis; 2007; 16(6):263-7. PubMed ID: 18035244
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet agents for prevention of recurrent ischemic stroke.
Hegge KA
S D Med; 2009 Jan; 62(1):15-7. PubMed ID: 19245087
[TBL] [Abstract][Full Text] [Related]
19. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole.
Weyrich AS; Skalabrin EJ; Kraiss LW
Am J Ther; 2009; 16(2):164-70. PubMed ID: 19300042
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerability of antiplatelet therapies for the secondary prevention of atherothrombotic disease.
Spinler SA
Pharmacotherapy; 2009 Jul; 29(7):812-21. PubMed ID: 19558255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]